Social Media Ideas for Boehringer Ingelheim

<![CDATA[How is Boehringer Ingelheim's Deliberate GLP-1 Strategy Different From Competitors?]]>

Boehringer bags PVT’s viral vector platform for cancer vaccine R&D

Boehringer Ingelheim has landed an exclusive license to Prime Vector Technologies’ viral vector platform for developing next-generation cancer vaccines.

<![CDATA[Eli Lilly and Abbisko Announce Drug Development Collaboration]]>

<![CDATA[Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio]]>

With $15M discovery deal, Boehringer becomes latest Big Pharma to buy into Immunai’s AI platform

TechBio outfit Immunai is continuing its parade of Big Pharma partnerships with its third such pact this year, this time with German drugmaker Boehringer Ingelheim.

<![CDATA[Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio]]>

Boehringer Ingelheim Launches Discovery Collaboration with Immunai to Identify Novel T-Cell Targets Across Oncology and...

Immunai, a leading AI biotech company specialized in mapping the human immune system, today announced a multi-project collaboration and an initial discovery program with Boehringe...

<![CDATA[Biogen Enters $1 Billion Agreement to Acquire RayThera Inc. ]]>

Guardant Health nabs FDA test approval to find patients for Boehringer’s new cancer drug

Boehringer Ingelheim’s Hernexeos has nabbed a companion diagnostic from Guardant Health after the FDA cleared its liquid biopsy test, Guardant360 CDx.

<![CDATA[Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand St...

<![CDATA[Where Does Boehringer Ingelheim Stand Between Oral or Injectable GLP-1’s Being The Future of Obesity Care?]]...

Beigene

Beigene Anonymous (not verified) Mon, 05/25/2026 - 11:38 field_thread_url https://cafepharma.com/boards/threads/beigene.637588/ board na...

HMC and Boehringer Ingelheim Sign Agreement to Advance Healthcare Innovation

Hamad Medical Corporation (HMC) has signed a memorandum of understanding with Boehringer Ingelheim to collaborate on initiatives aimed at strengthening clinical research, advancing...

Roche sticks with €600M diagnostics investment in Germany but warns of future risk

As news hit last week that Eli Lilly and Boehringer Ingelheim are cutting investments in Germany, Roche said it will not be following suit—for now.

Lilly, Boehringer to slash at least $1B each from planned investments in Germany

In response to a planned healthcare reform initiative in Germany that would reduce the prices of branded drugs, Eli Lilly and Boehringer Ingelheim have slashed their planned invest...

Boehringer Ingelheim: Boehringer Ingelheim streicht geplante Investitionen in Deutschland

Die Pharmakonzerne Boehringer Ingelheim und Eli Lilly streichen milliardenhohe Investitionen in Deutschland. Grund seien unter anderem die Sparpläne der Bundesregierung.

<![CDATA[Pharmaceutical Executive Daily: Eli Lilly and Abbisko Announce Drug Development Collaboration]]>

<![CDATA[Eli Lilly Enters Three Separate Acquisitions Totaling $3.83 Billion ]]>

<![CDATA[Novartis to Acquire Myricx Bio for $1.1 Billion]]>

<![CDATA[AlzeCure Enters $1 Billion Collaboration and Out-Licensing Agreement with Eli Lilly ]]>

<![CDATA[Ascidian and Eli Lilly Enter $1.9 Billion Global Research Collaboration to Develop RNA Exon Editors]]>

Boehringer Ingelheim khẳng định vị thế trong ngành chăn nuôi heo

Với vai trò Nhà tài trợ Kim cương tại IPVS 2026, Boehringer Ingelheim ghi dấu ấn với những chia sẻ chuyên môn và trải nghiệm tương tác, cam kết man...

<![CDATA[Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Joh...

<![CDATA[Novartis Announces $105 Million Collaborative Agreement with Antares Therapeutics]]>